Related Experiment Videos
Thoracic imaging in heart transplantation.
1Department of Radiology, Thoracic Imaging Section, UW Medical School, E3/311 Clinical Science Center, 600 Highland Avenue, Madison, WI 53792-3252, USA. jkuhlman@facstaff.wisc.edu
Journal of Thoracic Imaging
|April 17, 2002
Summary
Heart transplantation is the top treatment for end-stage heart failure. Advances in detecting and treating allograft rejection have improved long-term survival rates for heart transplant recipients.
Area of Science:
- Cardiology
- Immunology
- Radiology
Background:
- Heart transplantation is the optimal treatment for end-stage heart failure unresponsive to conventional therapies.
- Thoracic imaging is crucial for pre- and post-operative assessments in cardiac transplant patients.
Purpose of the Study:
- To review the primary complications following cardiac transplantation, focusing on acute allograft rejection.
- To highlight advancements in rejection treatment and their impact on patient survival.
Main Methods:
- Review of current literature on cardiac transplantation complications and management.
- Discussion of diagnostic tools such as endomyocardial biopsy.
- Analysis of immunosuppressive therapies and their efficacy.
Main Results:
- Acute allograft rejection is a major complication of heart transplantation.
- Improved immunosuppressive strategies and early detection via endomyocardial biopsy enhance survival.
- Estimated 1-year and 5-year survival rates are 79% and 65%, respectively.
Conclusions:
- Cardiac transplantation offers the best therapeutic option for advanced heart failure.
- Aggressive management of allograft rejection, supported by imaging and biopsy, significantly improves long-term outcomes for heart transplant recipients.